Skip to content

Lifecore Biomedical, Inc. LFCR Repayments of Long-Term Lines of Credit

Repayments of Long-Term Lines of Credit at other companies

StepStone Group Inc. logo
StepStone Group Inc.STEP
$18.75M-57.1%
MillerKnoll logo
MillerKnollMLKN
$243.8M-8.0%
PRA Group logo
PRA GroupPRAA
$124.46M+24.6%
APO
Apogee EnterprisesAPOG
$25M-24.2%
Richardson Electronics logo
Richardson ElectronicsRELL
$0
ATN International logo
ATN InternationalATNI
$15.13M-48.5%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s repayments of long-term lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s repayments of long-term lines of credit?
Lifecore Biomedical, Inc. (LFCR) reported repayments of long-term lines of credit of $36.4M in Q1 2026.